Latest Insider Transactions at Merck & Co., Inc. (MRK)
This section provides a real-time view of insider transactions for Merck & Co., Inc. (MRK). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Merck & Co., Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Merck & Co., Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Apr 25
2014
|
William B Harrison Jr Director |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+43.86%
|
$235,000
$47.23 P/Share
|
Apr 10
2014
|
Kenneth C Frazier Executive Chair |
SELL
Open market or private sale
|
Direct |
10,047
-1.58%
|
$572,679
$57.29 P/Share
|
Apr 10
2014
|
Kenneth C Frazier Executive Chair |
BUY
Exercise of conversion of derivative security
|
Direct |
12,876
+1.98%
|
$424,908
$33.47 P/Share
|
Apr 04
2014
|
Bruce N Kuhlik Exe V-P & Gen Counsel |
SELL
Open market or private sale
|
Direct |
145,225
-31.76%
|
$8,132,600
$56.44 P/Share
|
Apr 04
2014
|
Bruce N Kuhlik Exe V-P & Gen Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
145,225
+17.68%
|
$5,809,000
$40.66 P/Share
|
Oct 04
2011
|
Wendell P Weeks Director |
SELL
Open market or private sale
|
Indirect |
100
-100.0%
|
$3,100
$31.35 P/Share
|